… of adverse events (AEs) appears to differ between them at … a retrospective analysis of AEs
and drug efficacy in patients … received 250 mg gefitinib or 150 mg erlotinib once daily. The …

… less frequent and milder grade of adverse effects. However, comparable … retrospective
study showed comparable clinical efficacy of gefitinib, erlotinib, and afatinib in Japanese patients …

… , gefitinib, erlotinib and icotinib had similar effectiveness for the … study, a network meta-analysis
was performed to compare the effectiveness and adverse effects of gefitinib, erlotinib and …

… way to increase the effectiveness of these agents is to rationally select patients based on …
data from our lung cancer patients to compare the benefits derived from erlotinib and gefitinib …

… study was aimed to compare the effectiveness and safety of erlotinib and gefitinib in
NSCLC patients… The use of EGFR inhibitors can cause some adverse drug reactions (ADRs) …

… study was to compare the efficacy of gefitinib and erlotinib in … were enrolled into this
retrospective study conducted at five … some differences in the frequency of adverse effects between …

… , retrospective analyses had identified these subgroups as those most likely to benefit from
gefitinib and erlotinib [… death as an adverse event compared with the controls, were greater for …

… might be administered at a lower-than-standard dose to reduce adverse events while
retaining its efficacy. In fact, retrospective studies have shown that patients who were treated with …

… analysis of studies to compare the antitumor effectiveness and adverse effects (AEs) of gefitinib
and erlotinib … dose of erlotinib down to 25 mg/day in a retrospective study and achieved a …

… adverse events for afatinib, gefitinib, and erlotinib were approximately 7%, 3%, and 2%,
respectively, in our study, … efficacy in another retrospective study [19]. It showed that there was no …